Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Payables (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Payables for 6 consecutive years, with $8.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Payables fell 19.49% year-over-year to $8.5 million, compared with a TTM value of $8.5 million through Dec 2025, down 19.49%, and an annual FY2025 reading of $8.5 million, down 19.49% over the prior year.
  • Payables was $8.5 million for Q4 2025 at Treace Medical Concepts, down from $16.1 million in the prior quarter.
  • Across five years, Payables topped out at $21.1 million in Q1 2024 and bottomed at $1.3 million in Q1 2021.
  • Average Payables over 5 years is $9.7 million, with a median of $8.6 million recorded in 2022.
  • The sharpest move saw Payables surged 316.65% in 2024, then crashed 37.48% in 2025.
  • Year by year, Payables stood at $4.1 million in 2021, then surged by 113.71% to $8.7 million in 2022, then surged by 36.54% to $11.8 million in 2023, then decreased by 11.09% to $10.5 million in 2024, then decreased by 19.49% to $8.5 million in 2025.
  • Business Quant data shows Payables for TMCI at $8.5 million in Q4 2025, $16.1 million in Q3 2025, and $21.1 million in Q2 2025.